MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma

被引:119
|
作者
Jin, Mingpeng [1 ]
Wang, Jiaojiao [1 ]
Ji, Xiaoying [1 ]
Cao, Haiyan [1 ]
Zhu, Jianjun [1 ]
Chen, Yibing [2 ]
Yang, Jin [3 ]
Zhao, Zheng [4 ]
Ren, Tingting [1 ]
Xing, Jinliang [1 ]
机构
[1] Fourth Mil Med Univ, Teaching Ctr Basic Med, State Key Lab Canc Biol & Expt, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Ctr Genet & Prenatal Diag, Zhengzhou 450052, Henan, Peoples R China
[3] Northwest Univ, Sch Life Sci, Inst Prevent Genom Med, Xian 710069, Shaanxi, Peoples R China
[4] Shaanxi Prov Canc Hosp, Dept Med Oncol 3, Xian 710061, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Mitochondrial calcium uniporter regulator 1; Hepatocellular carcinoma; EMT; Metastasis; Notch; 1; ESSENTIAL COMPONENT; UNIPORTER; DEGRADATION; PROGRESSION; PROTEIN; NRF2;
D O I
10.1186/s13046-019-1135-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundMitochondrial Ca2+ plays a critical role in tumorigenesis, including cell proliferation and metastasis. Mitochondrial calcium uniporter regulator 1 (MCUR1) has been shown to be frequently upregulated in HCC and promote cancer cell survival. However, whether MCUR1 is involved in the metastasis of HCC and its underlying mechanisms remain unknown.MethodsThe effect of MCUR1 expression on epithelial-mesenchymal transition (EMT) in HCC cells was first evaluated by immunofluorescent staining and Western blot. Then, in vitro invasion and in vivo metastasis assays were used to evaluate the function of MCUR1 in HCC metastasis. The underlying mechanism has also been explored by investigating the effect of MCUR1 on ROS/Nrf2/Notch1 pathway.ResultsMCUR1 expression was significantly higher in HCC with metastasis and associated with tumor progression. MCUR1 promoted in vitro invasion and in vivo metastasis of HCC cells by promoting EMT via Snail. Mechanistically, MCUR1-mediated mitochondrial Ca2+ signaling promoted the EMT of HCC cells by activating ROS/Nrf2/Notch1 pathway. Inhibition of ROS production, mitochondrial Ca2+ uptake, Nrf2 expression or Notch1 activity significantly suppressed MCUR1-induced EMT of HCC cells. In addition, treatment with the mitochondrial Ca2+-buffering protein parvalbumin significantly inhibited ROS/Nrf2/Notch pathway and MCUR1-induced EMT and HCC metastasis.ConclusionsOur study provides evidence supporting a metastasis-promoting role for MCUR1-dependent mitochondrial Ca2+ uptake in HCC. Our findings suggest that MCUR1 may be a potential therapeutic target for HCC treatment.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma
    Mingpeng Jin
    Jiaojiao Wang
    Xiaoying Ji
    Haiyan Cao
    Jianjun Zhu
    Yibing Chen
    Jin Yang
    Zheng Zhao
    Tingting Ren
    Jinliang Xing
    Journal of Experimental & Clinical Cancer Research, 38
  • [2] LncRNA MALAT1 Regulates miR-144-3p to Facilitate Epithelial-Mesenchymal Transition of Lens Epithelial Cells via the ROS/NRF2/Notch1/Snail Pathway
    Ye, Wei
    Ma, Jiyuan
    Wang, Fang
    Wu, Tong
    He, Mengmei
    Li, Ji
    Pei, Rui
    Zhang, Luning
    Wang, Yafen
    Zhou, Jian
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
  • [3] Carbonic anhydrase 2 inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma
    Zhang, Chenyue
    Wang, Haiyong
    Chen, Zhiao
    Zhuang, Liping
    Xu, Litao
    Ning, Zhouyu
    Zhu, Zhenfeng
    Wang, Peng
    Meng, Zhiqiang
    CARCINOGENESIS, 2018, 39 (04) : 562 - 570
  • [4] Upregulated SSB Is Involved in Hepatocellular Carcinoma Progression and Metastasis through the Epithelial-Mesenchymal Transition, Antiapoptosis, and Altered ROS Level Pathway
    Wu H.
    Zhang Z.
    Han X.
    Zhang S.
    Zhang J.
    Han P.
    Zhang Y.
    Bai Y.
    Zhang Y.
    Oxidative Medicine and Cellular Longevity, 2023, 2023
  • [5] Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis
    Wang, Cun
    Jiang, Kai
    Kang, Xiaonan
    Gao, Dongmei
    Sun, Chun
    Li, Yan
    Sun, Lu
    Zhang, Shu
    Liu, Xiaohui
    Wu, Weizhong
    Yang, Pengyuan
    Guo, Kun
    Liu, Yinkun
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2012, 44 (12): : 2308 - 2320
  • [6] ROS-Nrf2 Pathway Mediates the Development of TGF-b1-Induced Epithelial-Mesenchymal Transition Through the Interaction with Notch Signaling
    Matsuno, Y.
    Matsuyama, M.
    Kiwamoto, T.
    Morishima, Y.
    Ishii, Y.
    Hizawa, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [7] FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma
    Fan-Di Meng
    Ji-Chao Wei
    Kai Qu
    Zhi-Xin Wang
    Qi-Fei Wu
    Ming-Hui Tai
    Hao-Chen Liu
    Rui-Yao Zhang
    Chang Liu
    World Journal of Gastroenterology, 2015, (01) : 196 - 213
  • [8] FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma
    Meng, Fan-Di
    Wei, Ji-Chao
    Qu, Kai
    Wang, Zhi-Xin
    Wu, Qi-Fei
    Tai, Ming-Hui
    Liu, Hao-Chen
    Zhang, Rui-Yao
    Liu, Chang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (01) : 196 - 213
  • [9] ROS-Nrf2 pathway mediates the development of TGF-β1-induced epithelial-mesenchymal transition through the activation of Notch signaling
    Yazaki, Kai
    Matsuno, Yosuke
    Yoshida, Kazufumi
    Sherpa, Mingma
    Nakajima, Masayuki
    Matsuyama, Masashi
    Kiwamoto, Takumi
    Morishima, Yuko
    Ishii, Yukio
    Hizawa, Nobuyuki
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2021, 100 (7-8)
  • [10] Six2 is negatively correlated with prognosis and facilitates epithelial-mesenchymal transition via TGF-β/Smad signal pathway in hepatocellular carcinoma
    Zheng-Hua Wan
    Yun-Han Ma
    Tian-Yi Jiang
    Yun-Kai Lin
    Yuan-Yuan Shi
    Ye-Xiong Tan
    Li-Wei Dong
    Hong-Yang Wang
    Hepatobiliary & Pancreatic Diseases International, 2019, 18 (06) : 525 - 531